Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H17ClN2O |
| Molecular Weight | 300.783 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCNC1=NC2=C(C=C(Cl)C=C2)[C@](C)(O1)C3=CC=CC=C3
InChI
InChIKey=IBYCYJFUEJQSMK-QGZVFWFLSA-N
InChI=1S/C17H17ClN2O/c1-3-19-16-20-15-10-9-13(18)11-14(15)17(2,21-16)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3,(H,19,20)/t17-/m1/s1
| Molecular Formula | C17H17ClN2O |
| Molecular Weight | 300.783 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
(R)-Etifoxine is an isomer, chemically isolated from Etifoxine (Stresam), an approved racemic drug (off patent) prescribed in Europe. (R)-Etifoxine was developed by Xytis Inc for treatment pain, mental disease, and central nervous system disorders. However future development has been discontinued.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:47:36 GMT 2025
by
admin
on
Mon Mar 31 22:47:36 GMT 2025
|
| Record UNII |
5KC5K5SST8
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
950522-63-1
Created by
admin on Mon Mar 31 22:47:36 GMT 2025 , Edited by admin on Mon Mar 31 22:47:36 GMT 2025
|
PRIMARY | |||
|
135564606
Created by
admin on Mon Mar 31 22:47:36 GMT 2025 , Edited by admin on Mon Mar 31 22:47:36 GMT 2025
|
PRIMARY | |||
|
5KC5K5SST8
Created by
admin on Mon Mar 31 22:47:36 GMT 2025 , Edited by admin on Mon Mar 31 22:47:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
RACEMATE -> ENANTIOMER |
